1. Home
  2. AMPH vs PLMR Comparison

AMPH vs PLMR Comparison

Compare AMPH & PLMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • PLMR
  • Stock Information
  • Founded
  • AMPH 1996
  • PLMR 2013
  • Country
  • AMPH United States
  • PLMR United States
  • Employees
  • AMPH N/A
  • PLMR N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • PLMR Property-Casualty Insurers
  • Sector
  • AMPH Health Care
  • PLMR Finance
  • Exchange
  • AMPH Nasdaq
  • PLMR Nasdaq
  • Market Cap
  • AMPH 2.5B
  • PLMR 2.9B
  • IPO Year
  • AMPH 2014
  • PLMR 2019
  • Fundamental
  • Price
  • AMPH $39.54
  • PLMR $104.93
  • Analyst Decision
  • AMPH Buy
  • PLMR Buy
  • Analyst Count
  • AMPH 4
  • PLMR 7
  • Target Price
  • AMPH $60.33
  • PLMR $111.67
  • AVG Volume (30 Days)
  • AMPH 607.1K
  • PLMR 172.1K
  • Earning Date
  • AMPH 11-06-2024
  • PLMR 02-12-2025
  • Dividend Yield
  • AMPH N/A
  • PLMR N/A
  • EPS Growth
  • AMPH 17.38
  • PLMR 49.11
  • EPS
  • AMPH 3.01
  • PLMR 4.22
  • Revenue
  • AMPH $723,549,000.00
  • PLMR $503,499,000.00
  • Revenue This Year
  • AMPH $16.86
  • PLMR N/A
  • Revenue Next Year
  • AMPH $10.07
  • PLMR $20.80
  • P/E Ratio
  • AMPH $13.01
  • PLMR $24.86
  • Revenue Growth
  • AMPH 20.33
  • PLMR 40.19
  • 52 Week Low
  • AMPH $36.56
  • PLMR $54.50
  • 52 Week High
  • AMPH $65.92
  • PLMR $112.90
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 30.89
  • PLMR 47.36
  • Support Level
  • AMPH $38.78
  • PLMR $103.14
  • Resistance Level
  • AMPH $45.39
  • PLMR $112.90
  • Average True Range (ATR)
  • AMPH 1.36
  • PLMR 3.98
  • MACD
  • AMPH -0.34
  • PLMR -0.98
  • Stochastic Oscillator
  • AMPH 15.69
  • PLMR 36.70

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About PLMR Palomar Holdings Inc. Common stock

Palomar Holdings Inc is a United States-based company focused on the provision of specialty property insurance earthquake, wind, and flood insurance products. The company's core focus is on the residential and commercial earthquake markets in earthquake-exposed states such as California, Oregon, Washington, and states with exposure to the New Madrid Seismic Zone. It offers specialty property insurance products in the target markets to both individuals and businesses through multiple channels, including retail agents, program administrators, wholesale brokers, and in partnership with other insurance companies. Its products include Residential Earthquake, Commercial Earthquake, Specialty Homeowners, Inland Marine, Commercial All Risk, Hawaii Hurricane, Residential Flood and others.

Share on Social Networks: